Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 40% ± 24% | |
endothelial cell | 6 studies | 24% ± 5% | |
astrocyte | 5 studies | 21% ± 4% | |
B cell | 4 studies | 17% ± 1% | |
GABAergic neuron | 4 studies | 40% ± 13% | |
non-classical monocyte | 3 studies | 25% ± 9% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 2% | |
epithelial cell | 3 studies | 34% ± 13% | |
lymphocyte | 3 studies | 24% ± 9% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 3% | |
dendritic cell | 3 studies | 23% ± 10% | |
macrophage | 3 studies | 23% ± 6% | |
oligodendrocyte | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 854.22 | 1445 / 1445 | 100% | 19.73 | 183 / 183 |
lung | 100% | 1147.61 | 578 / 578 | 100% | 15.77 | 1155 / 1155 |
ovary | 100% | 1038.68 | 180 / 180 | 100% | 18.51 | 430 / 430 |
prostate | 100% | 1050.75 | 245 / 245 | 100% | 16.34 | 502 / 502 |
stomach | 100% | 835.45 | 359 / 359 | 100% | 14.20 | 286 / 286 |
thymus | 100% | 1452.68 | 653 / 653 | 100% | 22.74 | 605 / 605 |
uterus | 100% | 1026.83 | 170 / 170 | 100% | 13.07 | 459 / 459 |
breast | 100% | 910.39 | 459 / 459 | 100% | 13.63 | 1116 / 1118 |
brain | 100% | 1109.88 | 2641 / 2642 | 100% | 15.19 | 704 / 705 |
intestine | 100% | 876.00 | 966 / 966 | 100% | 13.76 | 526 / 527 |
bladder | 100% | 864.57 | 21 / 21 | 100% | 13.28 | 503 / 504 |
adrenal gland | 100% | 1482.10 | 258 / 258 | 100% | 19.61 | 229 / 230 |
kidney | 100% | 794.55 | 89 / 89 | 98% | 11.84 | 881 / 901 |
pancreas | 99% | 523.02 | 324 / 328 | 99% | 12.20 | 176 / 178 |
liver | 100% | 596.92 | 226 / 226 | 96% | 6.98 | 391 / 406 |
skin | 100% | 922.14 | 1808 / 1809 | 94% | 13.55 | 446 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.68 | 29 / 29 |
spleen | 100% | 1281.52 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.70 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.71 | 1 / 1 |
adipose | 100% | 1004.30 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1161.63 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 435.23 | 834 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 1227.58 | 888 / 929 | 0% | 0 | 0 / 0 |
muscle | 88% | 302.90 | 709 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 8.07 | 65 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0016567 | Biological process | protein ubiquitination |
GO_0005515 | Molecular function | protein binding |
Gene name | FBXO33 |
Protein name | F-box only protein 33 F-box protein 33 |
Synonyms | FBX33 |
Description | FUNCTION: Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Probably recognizes and binds to phosphorylated target proteins. Recognizes YBX1 (By similarity). . |
Accessions | ENST00000298097.8 Q7Z6M2 G3V3J7 ENST00000554190.1 |